The Life Sciences Innovative Manufacturing Fund (LSIMF)
Department for Science, Innovation and Technology
Award
£1m – £130m
Total fund Up to £520m
Deadline
Closes 31 March 2030
Where
UK-wide
Summary
UK registered businesses can apply for funding for life science manufacturing capital investment projects which help increase UK health resilience.
Who can apply
Your company To be eligible to apply for the fund, your company must be: A UK registered company, or a UK registered establishment UK establishments must also have at least one UK registered company in their group structure A wholly private sector business A product developer, contract development manufacturing organisation, or a generics manufacturer. Applicants must also be able to provide two years of audited accounts for the applicant company (and/or if applicable, parent entity). If this is not available – for example because the company is not required by Companies House to submit audited accounts – we will ask for demonstration that the remaining funding required for the project to go ahead is available. You may be also asked for evidence that your company (or if applicable, parent entity) has a track record of successfully manufacturing medicines or medical devices in the UK or abroad, or that you have successfully developed a product intended for commercial scale-up. Your project To be eligible for the fund, your project must: Have a total eligible cost of at least £8 million . Eligible costs include capital, R&D and skills/training expenditure. This should exclude operational expenditure. Be located in the UK Be primarily a capital investment Be a single company investment, or a joint investment between multiple entities within the same company group structure (as opposed to forming a partnership between independent companies or other types of organisations) Require only the amount of grant requested to proceed. For example, without the specific amount of funding you are requesting your project wouldn’t go ahead or go ahead at a smaller scale, go ahead overseas or would be significantly delayed (3 years or more) Your project must be a manufacturing project for the manufacture of: Human medicines (this includes both the manufacture of active pharmaceutical ingredients (API) / drug substance and finished product / drug product) Medical diagnostics – for both disease identification and monitoring MedTech products – all types of medical devices related to human health. The fund is open to applications for MHRA-licenced medicines, medical and diagnostic devices registered with the MHRA, and products in development where approval to market or manufacture the medicine or device in the UK is intended to be sought for commercial scale-up, for example a manufacturing project for clinical trials or investigational studies. Manufacturing facilities are required to work to Good Manufacturing Practice (GMP) and the facility be intended to support clinical and/or commercial manufacture of API or drug product. Manufacturers of medicinal diagnostics and medical devices must confirm that their device meets or intends to meet the requirements of the Medical Devices Regulations 2002. Projects relating to the following are not eligible for funding from LSIMF: Veterinary medicine Herbal medicines Nutritional supplements or vitamins Raw ingredients (e.g solvents, buffers and cleaning agents) The production of single-use consumables that are not integrated into a larger product (e.g manufacturing syringes independently from diagnostic kits) Secondary packaging for products or materials (e.g package inserts, labelling and boxes).
Full details
The Life Sciences Innovative Manufacturing Fund (LSIMF) is a capital grants fund which aims to build resilience for future health emergencies and capitalise on the UK’s world-leading research and development capabilities. The fund will enhance and accelerate affordable access to mature, new and emerging Life Sciences products for both pandemic and non-pandemic scenarios. LSIMF will provide up to £520 million in capital grants for investment in the manufacture of human medicines and medical technology (including diagnostics, and MedTech products). This is a new fund from previous UK Government Life Sciences manufacturing funds. LSIMF is open to all eligible companies, including previous manufacturing grant recipients, as long as the application is for a different project. Projects with a total cost (including capital expenditure) of at least £8 million are eligible to apply. The maximum intervention rate (ratio of grant to project costs) is 25%, with the typical intervention rate being 10-20% of your total project costs. For example, for a project with a total cost of £100m, the typical grant awarded might be £10-20m.